{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T11:08:59Z","timestamp":1745320139916},"reference-count":12,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2023]]},"DOI":"10.3960\/jslrt.22029","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T22:11:19Z","timestamp":1679955079000},"page":"32-36","source":"Crossref","is-referenced-by-count":2,"title":["Development of rapidly fatal TAFRO syndrome-like features in a patient with essential thrombocythemia"],"prefix":"10.3960","volume":"63","author":[{"given":"Hiroko","family":"Iizuka-Honma","sequence":"first","affiliation":[{"name":"Department of Hematology, Juntendo University Urayasu Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruko","family":"Takizawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University Urayasu Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Nitta","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University Urayasu Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Mitsumori","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University Urayasu Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University Urayasu Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Takai K, Nikkuni K, Shibuya H, Hashidate H. [Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly]. Rinsho Ketsueki. 2010; 51: 320-325 [in Japanese]."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Fujimoto S, Sakai T, Kawabata H et al.<\/i> Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease? Am J Hematol. 2019; 94: 975-983.","DOI":"10.1002\/ajh.25554"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Masaki Y, Kawabata H, Takai K et al.<\/i> Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version. Int J Hematol. 2016; 103: 686-692.","DOI":"10.1007\/s12185-016-1979-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Masaki Y, Kawabata H, Takai K et al.<\/i> 2019 Updated diagnostic criteria and disease severity classification for TAFRO syndrome. Int J Hematol. 2020; 111: 155-158.","DOI":"10.1007\/s12185-019-02780-1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Tefferi A, Pardanani A. Essential Thrombocythemia. N Engl J Med. 2019; 381: 2135-2144.","DOI":"10.1056\/NEJMcp1816082"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Arber DA, Orazi A, Hasserjian R et al.<\/i> The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016; 127: 2391-2405.","DOI":"10.1182\/blood-2016-03-643544"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Tefferi A, Wassie EA, Guglielmelli P et al.<\/i> Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: a collaborative study of 1027 patients. Am J Hematol. 2014; 89: E121-E124.","DOI":"10.1002\/ajh.23743"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Nishimura Y, Hanayama Y, Fujii N, Kondo E, Otsuka F. Comparison of the clinical characteristics of TAFRO syndrome and idiopathic multicentric Castleman disease in general internal medicine: a 6\u2010year retrospective study. Intern Med J. 2020; 50: 184-191.","DOI":"10.1111\/imj.14404"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Liu AY, Nabel CS, Finkelman BS et al.<\/i> Idiopathic multicentric Castleman\u2019s disease: a systematic literature review. Lancet Haematol. 2016; 3: e163-e175.","DOI":"10.1016\/S2352-3026(16)00006-5"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Hoermann G, Greiner G, Valent P. Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms. Mediators Inflamm. 2015; 2015: 869242.","DOI":"10.1155\/2015\/869242"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Gadomska G, Bartoszewska-Kubiak A, Boinska J et al.<\/i> Selected Parameters of Angiogenesis and the JAK2, CALR, and MPL Mutations in Patients With Essential Thrombocythemia. Clin Appl Thromb Hemost. 2018; 24: 1056-1060.","DOI":"10.1177\/1076029617740222"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Cacemiro MC, Cominal JG, Tognon R et al.<\/i> Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation. Hematol Transfus Cell Ther. 2018; 40: 120-131.","DOI":"10.1016\/j.htct.2017.12.003"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/63\/1\/63_22029\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T05:25:04Z","timestamp":1680326704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/63\/1\/63_22029\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.22029","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"22029"}}